These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15203029)
1. Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood-brain barrier. Escuder-Gilabert L; Molero-Monfort M; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):193-201. PubMed ID: 15203029 [TBL] [Abstract][Full Text] [Related]
2. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols. Stępnik KE; Malinowska I J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703 [TBL] [Abstract][Full Text] [Related]
3. Biopartitioning micellar chromatography to predict blood to lung, blood to liver, blood to fat and blood to skin partition coefficients of drugs. Martín-Biosca Y; Torres-Cartas S; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ Anal Chim Acta; 2009 Jan; 632(2):296-303. PubMed ID: 19110108 [TBL] [Abstract][Full Text] [Related]
5. Characterization of biopartitioning micellar chromatography system using monolithic column by linear solvation energy relationship and application to predict blood-brain barrier penetration. Lu R; Sun J; Wang Y; Li H; Liu J; Fang L; He Z J Chromatogr A; 2009 Jul; 1216(27):5190-8. PubMed ID: 19481214 [TBL] [Abstract][Full Text] [Related]
6. Development of predictive retention-activity models of butyrophenones by biopartitioning micellar chromatography. Martín-Biosca Y; Molero-Monfort M; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ Biomed Chromatogr; 2001 Aug; 15(5):334-41. PubMed ID: 11507715 [TBL] [Abstract][Full Text] [Related]
7. Development of predictive quantitative retention-activity relationship models of HMG-CoA reductase inhibitors by biopartitioning micellar chromatography. Wang SR; Chen Y; Wu LP; Miao WJ; Xiong MJ; Chen C; Zhong ZR; Ye LM J Pharm Biomed Anal; 2008 Jan; 46(2):243-9. PubMed ID: 18024049 [TBL] [Abstract][Full Text] [Related]
8. An LD50 model for predicting psychotropic drug toxicity using biopartitioning micellar chromatography. Quiñones-Torrelo C; Sagrado-Vives S; Villanueva-Camañas RM; Medina-Hernández MJ Biomed Chromatogr; 2001 Feb; 15(1):31-40. PubMed ID: 11180298 [TBL] [Abstract][Full Text] [Related]
9. Biopartitioning micellar chromatography: an in vitro technique for predicting human drug absorption. Molero-Monfort M; Escuder-Gilabert L; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):225-36. PubMed ID: 11334335 [TBL] [Abstract][Full Text] [Related]
11. Predicting blood-brain barrier penetration of drugs by microemulsion liquid chromatography with corrected retention factor. Liu J; Sun J; Sui X; Wang Y; Hou Y; He Z J Chromatogr A; 2008 Jul; 1198-1199():164-72. PubMed ID: 18541248 [TBL] [Abstract][Full Text] [Related]
12. Estimation of the effect of the acidosis and alkalosis on the anesthetic potency of local anesthetics by biopartitioning micellar chromatography and micellar electrokinetic chromatography. Canós-Rius N; Martín-Biosca Y; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ Eur J Med Chem; 2005 Feb; 40(2):215-23. PubMed ID: 15694657 [TBL] [Abstract][Full Text] [Related]
14. Biopartitioning micellar chromatography with sodium dodecyl sulfate as a pseudo α(1)-acid glycoprotein to the prediction of protein-drug binding. Hadjmohammadi M; Salary M J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 912():50-5. PubMed ID: 23261822 [TBL] [Abstract][Full Text] [Related]
15. Ionization-specific QSAR models of blood-brain penetration of drugs. Lanevskij K; Japertas P; Didziapetris R; Petrauskas A Chem Biodivers; 2009 Nov; 6(11):2050-4. PubMed ID: 19937840 [TBL] [Abstract][Full Text] [Related]
16. Predicting drug penetration across the blood-brain barrier: comparison of micellar liquid chromatography and immobilized artificial membrane liquid chromatography. De Vrieze M; Lynen F; Chen K; Szucs R; Sandra P Anal Bioanal Chem; 2013 Jul; 405(18):6029-41. PubMed ID: 23719933 [TBL] [Abstract][Full Text] [Related]
17. Mixed micellar liquid chromatography methods: modelling quantitative retention-activity relationships of angiotensin converting enzyme inhibitors. Wu LP; Cui Y; Xiong MJ; Wang SR; Chen C; Ye LM Biomed Chromatogr; 2008 Nov; 22(11):1243-51. PubMed ID: 18651592 [TBL] [Abstract][Full Text] [Related]
18. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564 [TBL] [Abstract][Full Text] [Related]
19. Retention-activity relationship studies of benzodiazepines by micellar liquid chromatography. Molero-Monfort M; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ Biomed Chromatogr; 1999 Oct; 13(6):394-400. PubMed ID: 10477896 [TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates. Adenot M; Lahana R J Chem Inf Comput Sci; 2004; 44(1):239-48. PubMed ID: 14741033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]